Spire Healthcare Proceeds with Sale Discussions
Spire Healthcare, a UK-listed private hospital operator, has confirmed that discussions for a potential sale of the business are ongoing, even after private equity firms Bridgepoint and Triton stated they will not make an offer, according to a report by Reuters as covered in Private Equity Wire. The company launched a strategic review in September 2025 and revealed in January that it was in talks with multiple potential bidders, including Bridgepoint and Triton.
Reasons for Withdrawal by Bidders
Bridgepoint explained that it could not reach a deal structure satisfying all stakeholders, while Triton did not provide reasons for its decision to step away, as noted in the same report. Additionally, reporting from Sky News had indicated that Bridgepoint was exploring a bid exceeding £1bn for Spire.
Spire’s Operations and Market Position
Spire operates 38 hospitals and more than 50 clinics, medical centres, and consulting rooms across the UK, with a market capitalisation of around £765m according to LSEG data. The company has stated that its board and management are evaluating alternative actions to enhance long-term shareholder value, according to Private Equity Wire.
Future Uncertainties in the Process
Spire cautioned that it continues to engage with other parties, but there is no certainty that a transaction will occur or what terms it might involve, as detailed in the report. This reflects the fluid nature of the sale process amid ongoing strategic considerations.
